{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:52:12Z","timestamp":1768434732774,"version":"3.49.0"},"reference-count":22,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3892\/ol.2012.771","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T19:08:12Z","timestamp":1340392092000},"page":"551-555","source":"Crossref","is-referenced-by-count":7,"title":["The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma"],"prefix":"10.3892","volume":"4","author":[{"given":"MATEUSZ","family":"BUJKO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAGDALENA","family":"KOWALEWSKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNA","family":"DANSKA-BIDZINSKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELWIRA","family":"BAKULA-ZALEWSKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JANUSZ A.","family":"SIEDECKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARIUSZ","family":"BIDZINSKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,6,22]]},"reference":[{"key":"key20180108091719_b1-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989\u20131999","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180108091719_b2-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D\u2019Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"Suppl 4","key":"key20180108091719_b3-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"key":"key20180108091719_b4-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-7819-7-38","article-title":"Treatment of early uterine sarcomas: disentangling adjuvant modalities","volume":"7","author":"Zagouri","year":"2009","journal-title":"World J Surg Oncol"},{"key":"key20180108091719_b5-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00280-006-0210-0","article-title":"A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma","volume":"58","author":"Ryan","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180108091719_b6-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0959-8049(98)00403-1","article-title":"Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group","volume":"35","author":"Woll","year":"1999","journal-title":"Eur J Cancer"},{"key":"key20180108091719_b7-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/cncr.11875","article-title":"A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas","volume":"98","author":"Trent","year":"2003","journal-title":"Cancer"},{"key":"key20180108091719_b8-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/cncr.11730","article-title":"A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma","volume":"98","author":"Talbot","year":"2003","journal-title":"Cancer"},{"key":"key20180108091719_b9-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/cncr.21384","article-title":"A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas","volume":"104","author":"Garcia del Muro","year":"2005","journal-title":"Cancer"},{"key":"key20180108091719_b10-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2005.03.018","article-title":"Temozolomide in uterine leiomyosarcomas","volume":"98","author":"Anderson","year":"2005","journal-title":"Gynecol Oncol"},{"key":"key20180108091719_b11-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/IGC.0b013e3181c7fe53","article-title":"Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series","volume":"20","author":"Ferriss","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"key20180108091719_b12-ol-04-03-0551","first-page":"793","article-title":"Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia","volume":"59","author":"Esteller","year":"1999","journal-title":"Cancer Res"},{"key":"key20180108091719_b13-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1098-2744(199902)24:2<90::AID-MC3>3.0.CO;2-B","article-title":"A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers","volume":"24","author":"Herfarth","year":"1999","journal-title":"Mol Carcinog"},{"key":"key20180108091719_b14-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/carcin\/12.10.1857","article-title":"Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents","volume":"12","author":"Kaina","year":"1991","journal-title":"Carcinogenesis"},{"key":"key20180108091719_b15-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1586\/14737140.8.11.1781","article-title":"Association between response to primary treatments and MGMT status in glioblastoma","volume":"8","author":"Franceschi","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180108091719_b16-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/sj.bjc.6605796","article-title":"MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome","volume":"103","author":"Hassel","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180108091719_b17-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2407-9-123","article-title":"Quantitation of DNA methylation by melt curve analysis","volume":"9","author":"Smith","year":"2009","journal-title":"BMC Cancer"},{"key":"key20180108091719_b18-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clinbiochem.2012.01.001","article-title":"Identification of suitable reference genes for gene expression measurement in uterine sarcoma and carcinosarcoma tumors","volume":"45","author":"Kowalewska","year":"2012","journal-title":"Clin Biochem"},{"key":"key20180108091719_b19-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gkl767","article-title":"qPrimerDepot: a primer database for quantitative real time PCR","volume":"35","author":"Cui","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"key20180108091719_b20-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.dnarep.2007.03.013","article-title":"MGMT hypermethylation: a prognostic foe, a predictive friend","volume":"6","author":"Jacinto","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"key20180108091719_b21-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180108091719_b22-ol-04-03-0551","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1750-3639.2008.00153.x","article-title":"Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker","volume":"18","author":"Preusser","year":"2008","journal-title":"Brain Pathol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.771\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:29:01Z","timestamp":1714091341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,22]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6,22]]},"published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.3892\/ol.2012.771"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.771","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,22]]}}}